felbamate has been researched along with Chronic Progressive Epilepsia Partialis Continua in 1 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, JR | 1 |
| Fuller, T | 1 |
1 other study available for felbamate and Chronic Progressive Epilepsia Partialis Continua
| Article | Year |
|---|---|
The use of felbamate in patients with periodic lateralized epileptiform discharges (PLEDs).
Topics: Anticonvulsants; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; E | 1995 |